MIND-USA
2018
Modifying the Impact of ICU-Associated Neurological Dysfunction
In 566 ICU patients with delirium, haloperidol or ziprasidone did not change delirium duration versus placebo.
Result
Primary endpoint: Days alive without delirium or coma
Median days alive without delirium/coma: 8.5 (placebo) vs 7.9 (haloperidol) vs 8.7 (ziprasidone); P=0.26 overall. No difference.
- Subtopic
- Delirium
- Design
- Multicentre RCT, USA
- Relevance
- Important: one of several pillars.
- Source
- Girard TD, et al. N Engl J Med. 2018;379(26):2506-2516.doi 10.1056/NEJMoa1808217
Discussion & critique
Killed routine antipsychotic prophylaxis/treatment for ICU delirium.